Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$533K Sell
1,515
-1,899
-56% -$677K 0.08% 185
2025
Q4
$1.12M Buy
3,414
+1,075
+46% +$341K 0.18% 104
2025
Q3
$660K Buy
2,339
+855
+58% +$248K 0.12% 140
2025
Q2
$414K Buy
1,484
+64
+5% +$18.1K 0.08% 168
2025
Q1
$442K Sell
1,420
-860
-38% -$254K 0.1% 145
2024
Q4
$594K Buy
2,280
+143
+7% +$42.4K 0.13% 137
2024
Q3
$689K Sell
2,137
-809
-27% -$265K 0.16% 100
2024
Q2
$921K Sell
2,946
-1,894
-39% -$556K 0.22% 75
2024
Q1
$1.38M Sell
4,840
-252
-5% -$73.7K 0.34% 62
2023
Q4
$1.47M Buy
+5,092
New +$1.39M 0.35% 57

Other funds holding AMGN

Tyche Wealth Partners's AMGN Position: Q1 2026 in Review

Tyche Wealth Partners reduced its Amgen (AMGN) stake by 56% in Q1 2026, selling an estimated $677K and leaving 1,515 shares worth $533K. The position accounts for 0.08% of the portfolio, ranked #185.

Tyche Wealth Partners first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.47M in Q4 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Tyche Wealth Partners held 1,515 shares of Amgen worth $533K as of Q1 2026.
  • Tyche Wealth Partners sold 1,899 Amgen shares in Q1 2026, an estimated $677K.
  • Amgen made up 0.08% of Tyche Wealth Partners's portfolio in Q1 2026, its #185 holding.
  • Tyche Wealth Partners first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Tyche Wealth Partners's Amgen position peaked at $1.47M in Q4 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.